Biosimilar Drug Market - Global Outlook and Forecast 2023-2028

Report ID: 1030363 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Biosimilar Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Biosimilar Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Drug Overall Market Size
    2.1 Global Biosimilar Drug Market Size: 2021 VS 2028
    2.2 Global Biosimilar Drug Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Biosimilar Drug Sales: 2017-2028
3 Company Landscape
    3.1 Top Biosimilar Drug Players in Global Market
    3.2 Top Global Biosimilar Drug Companies Ranked by Revenue
    3.3 Global Biosimilar Drug Revenue by Companies
    3.4 Global Biosimilar Drug Sales by Companies
    3.5 Global Biosimilar Drug Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Biosimilar Drug Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Biosimilar Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Drug Players in Global Market
        3.8.1 List of Global Tier 1 Biosimilar Drug Companies
        3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Drug Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Biosimilar Drug Market Size Markets, 2021 & 2028
        4.1.2 Injection
        4.1.3 Tablets
        4.1.4 Other Types
    4.2 By Type - Global Biosimilar Drug Revenue & Forecasts
        4.2.1 By Type - Global Biosimilar Drug Revenue, 2017-2022
        4.2.2 By Type - Global Biosimilar Drug Revenue, 2023-2028
        4.2.3 By Type - Global Biosimilar Drug Revenue Market Share, 2017-2028
    4.3 By Type - Global Biosimilar Drug Sales & Forecasts
        4.3.1 By Type - Global Biosimilar Drug Sales, 2017-2022
        4.3.2 By Type - Global Biosimilar Drug Sales, 2023-2028
        4.3.3 By Type - Global Biosimilar Drug Sales Market Share, 2017-2028
    4.4 By Type - Global Biosimilar Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Biosimilar Drug Market Size, 2021 & 2028
        5.1.2 Ankylosing Spondylitis
        5.1.3 Tumor
        5.1.4 Rheumatoid Arthrtis
        5.1.5 Cardiovascular
        5.1.6 Other Application
    5.2 By Application - Global Biosimilar Drug Revenue & Forecasts
        5.2.1 By Application - Global Biosimilar Drug Revenue, 2017-2022
        5.2.2 By Application - Global Biosimilar Drug Revenue, 2023-2028
        5.2.3 By Application - Global Biosimilar Drug Revenue Market Share, 2017-2028
    5.3 By Application - Global Biosimilar Drug Sales & Forecasts
        5.3.1 By Application - Global Biosimilar Drug Sales, 2017-2022
        5.3.2 By Application - Global Biosimilar Drug Sales, 2023-2028
        5.3.3 By Application - Global Biosimilar Drug Sales Market Share, 2017-2028
    5.4 By Application - Global Biosimilar Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Biosimilar Drug Market Size, 2021 & 2028
    6.2 By Region - Global Biosimilar Drug Revenue & Forecasts
        6.2.1 By Region - Global Biosimilar Drug Revenue, 2017-2022
        6.2.2 By Region - Global Biosimilar Drug Revenue, 2023-2028
        6.2.3 By Region - Global Biosimilar Drug Revenue Market Share, 2017-2028
    6.3 By Region - Global Biosimilar Drug Sales & Forecasts
        6.3.1 By Region - Global Biosimilar Drug Sales, 2017-2022
        6.3.2 By Region - Global Biosimilar Drug Sales, 2023-2028
        6.3.3 By Region - Global Biosimilar Drug Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Biosimilar Drug Revenue, 2017-2028
        6.4.2 By Country - North America Biosimilar Drug Sales, 2017-2028
        6.4.3 US Biosimilar Drug Market Size, 2017-2028
        6.4.4 Canada Biosimilar Drug Market Size, 2017-2028
        6.4.5 Mexico Biosimilar Drug Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Biosimilar Drug Revenue, 2017-2028
        6.5.2 By Country - Europe Biosimilar Drug Sales, 2017-2028
        6.5.3 Germany Biosimilar Drug Market Size, 2017-2028
        6.5.4 France Biosimilar Drug Market Size, 2017-2028
        6.5.5 U.K. Biosimilar Drug Market Size, 2017-2028
        6.5.6 Italy Biosimilar Drug Market Size, 2017-2028
        6.5.7 Russia Biosimilar Drug Market Size, 2017-2028
        6.5.8 Nordic Countries Biosimilar Drug Market Size, 2017-2028
        6.5.9 Benelux Biosimilar Drug Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Biosimilar Drug Revenue, 2017-2028
        6.6.2 By Region - Asia Biosimilar Drug Sales, 2017-2028
        6.6.3 China Biosimilar Drug Market Size, 2017-2028
        6.6.4 Japan Biosimilar Drug Market Size, 2017-2028
        6.6.5 South Korea Biosimilar Drug Market Size, 2017-2028
        6.6.6 Southeast Asia Biosimilar Drug Market Size, 2017-2028
        6.6.7 India Biosimilar Drug Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Biosimilar Drug Revenue, 2017-2028
        6.7.2 By Country - South America Biosimilar Drug Sales, 2017-2028
        6.7.3 Brazil Biosimilar Drug Market Size, 2017-2028
        6.7.4 Argentina Biosimilar Drug Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Biosimilar Drug Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Biosimilar Drug Sales, 2017-2028
        6.8.3 Turkey Biosimilar Drug Market Size, 2017-2028
        6.8.4 Israel Biosimilar Drug Market Size, 2017-2028
        6.8.5 Saudi Arabia Biosimilar Drug Market Size, 2017-2028
        6.8.6 UAE Biosimilar Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 CP Guojian Pharma
        7.1.1 CP Guojian Pharma Corporate Summary
        7.1.2 CP Guojian Pharma Business Overview
        7.1.3 CP Guojian Pharma Biosimilar Drug Major Product Offerings
        7.1.4 CP Guojian Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.1.5 CP Guojian Pharma Key News
    7.2 Biotech Pharma
        7.2.1 Biotech Pharma Corporate Summary
        7.2.2 Biotech Pharma Business Overview
        7.2.3 Biotech Pharma Biosimilar Drug Major Product Offerings
        7.2.4 Biotech Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.2.5 Biotech Pharma Key News
    7.3 Celgen Pharma
        7.3.1 Celgen Pharma Corporate Summary
        7.3.2 Celgen Pharma Business Overview
        7.3.3 Celgen Pharma Biosimilar Drug Major Product Offerings
        7.3.4 Celgen Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.3.5 Celgen Pharma Key News
    7.4 Henlius
        7.4.1 Henlius Corporate Summary
        7.4.2 Henlius Business Overview
        7.4.3 Henlius Biosimilar Drug Major Product Offerings
        7.4.4 Henlius Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.4.5 Henlius Key News
    7.5 Amgen
        7.5.1 Amgen Corporate Summary
        7.5.2 Amgen Business Overview
        7.5.3 Amgen Biosimilar Drug Major Product Offerings
        7.5.4 Amgen Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.5.5 Amgen Key News
    7.6 Eli Lilly
        7.6.1 Eli Lilly Corporate Summary
        7.6.2 Eli Lilly Business Overview
        7.6.3 Eli Lilly Biosimilar Drug Major Product Offerings
        7.6.4 Eli Lilly Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.6.5 Eli Lilly Key News
    7.7 Sandoz
        7.7.1 Sandoz Corporate Summary
        7.7.2 Sandoz Business Overview
        7.7.3 Sandoz Biosimilar Drug Major Product Offerings
        7.7.4 Sandoz Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.7.5 Sandoz Key News
    7.8 Changchun High Tech
        7.8.1 Changchun High Tech Corporate Summary
        7.8.2 Changchun High Tech Business Overview
        7.8.3 Changchun High Tech Biosimilar Drug Major Product Offerings
        7.8.4 Changchun High Tech Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.8.5 Changchun High Tech Key News
    7.9 Innovent
        7.9.1 Innovent Corporate Summary
        7.9.2 Innovent Business Overview
        7.9.3 Innovent Biosimilar Drug Major Product Offerings
        7.9.4 Innovent Biosimilar Drug Sales and Revenue in Global (2017-2022)
        7.9.5 Innovent Key News
8 Global Biosimilar Drug Production Capacity, Analysis
    8.1 Global Biosimilar Drug Production Capacity, 2017-2028
    8.2 Biosimilar Drug Production Capacity of Key Manufacturers in Global Market
    8.3 Global Biosimilar Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Biosimilar Drug Supply Chain Analysis
    10.1 Biosimilar Drug Industry Value Chain
    10.2 Biosimilar Drug Upstream Market
    10.3 Biosimilar Drug Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Biosimilar Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Biosimilar Drug in Global Market
    Table 2. Top Biosimilar Drug Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Biosimilar Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Biosimilar Drug Revenue Share by Companies, 2017-2022
    Table 5. Global Biosimilar Drug Sales by Companies, (K Dose), 2017-2022
    Table 6. Global Biosimilar Drug Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Biosimilar Drug Price (2017-2022) & (USD/Dose)
    Table 8. Global Manufacturers Biosimilar Drug Product Type
    Table 9. List of Global Tier 1 Biosimilar Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Biosimilar Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Biosimilar Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Biosimilar Drug Sales (K Dose), 2017-2022
    Table 15. By Type - Global Biosimilar Drug Sales (K Dose), 2023-2028
    Table 16. By Application – Global Biosimilar Drug Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Biosimilar Drug Sales (K Dose), 2017-2022
    Table 20. By Application - Global Biosimilar Drug Sales (K Dose), 2023-2028
    Table 21. By Region – Global Biosimilar Drug Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Biosimilar Drug Sales (K Dose), 2017-2022
    Table 25. By Region - Global Biosimilar Drug Sales (K Dose), 2023-2028
    Table 26. By Country - North America Biosimilar Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Biosimilar Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Biosimilar Drug Sales, (K Dose), 2017-2022
    Table 29. By Country - North America Biosimilar Drug Sales, (K Dose), 2023-2028
    Table 30. By Country - Europe Biosimilar Drug Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Biosimilar Drug Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Biosimilar Drug Sales, (K Dose), 2017-2022
    Table 33. By Country - Europe Biosimilar Drug Sales, (K Dose), 2023-2028
    Table 34. By Region - Asia Biosimilar Drug Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Biosimilar Drug Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Biosimilar Drug Sales, (K Dose), 2017-2022
    Table 37. By Region - Asia Biosimilar Drug Sales, (K Dose), 2023-2028
    Table 38. By Country - South America Biosimilar Drug Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Biosimilar Drug Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Biosimilar Drug Sales, (K Dose), 2017-2022
    Table 41. By Country - South America Biosimilar Drug Sales, (K Dose), 2023-2028
    Table 42. By Country - Middle East & Africa Biosimilar Drug Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Biosimilar Drug Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Biosimilar Drug Sales, (K Dose), 2017-2022
    Table 45. By Country - Middle East & Africa Biosimilar Drug Sales, (K Dose), 2023-2028
    Table 46. CP Guojian Pharma Corporate Summary
    Table 47. CP Guojian Pharma Biosimilar Drug Product Offerings
    Table 48. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 49. Biotech Pharma Corporate Summary
    Table 50. Biotech Pharma Biosimilar Drug Product Offerings
    Table 51. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 52. Celgen Pharma Corporate Summary
    Table 53. Celgen Pharma Biosimilar Drug Product Offerings
    Table 54. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 55. Henlius Corporate Summary
    Table 56. Henlius Biosimilar Drug Product Offerings
    Table 57. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 58. Amgen Corporate Summary
    Table 59. Amgen Biosimilar Drug Product Offerings
    Table 60. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 61. Eli Lilly Corporate Summary
    Table 62. Eli Lilly Biosimilar Drug Product Offerings
    Table 63. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 64. Sandoz Corporate Summary
    Table 65. Sandoz Biosimilar Drug Product Offerings
    Table 66. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 67. Changchun High Tech Corporate Summary
    Table 68. Changchun High Tech Biosimilar Drug Product Offerings
    Table 69. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 70. Innovent Corporate Summary
    Table 71. Innovent Biosimilar Drug Product Offerings
    Table 72. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
    Table 73. Biosimilar Drug Production Capacity (K Dose) of Key Manufacturers in Global Market, 2020-2022 (K Dose)
    Table 74. Global Biosimilar Drug Capacity Market Share of Key Manufacturers, 2020-2022
    Table 75. Global Biosimilar Drug Production by Region, 2017-2022 (K Dose)
    Table 76. Global Biosimilar Drug Production by Region, 2023-2028 (K Dose)
    Table 77. Biosimilar Drug Market Opportunities & Trends in Global Market
    Table 78. Biosimilar Drug Market Drivers in Global Market
    Table 79. Biosimilar Drug Market Restraints in Global Market
    Table 80. Biosimilar Drug Raw Materials
    Table 81. Biosimilar Drug Raw Materials Suppliers in Global Market
    Table 82. Typical Biosimilar Drug Downstream
    Table 83. Biosimilar Drug Downstream Clients in Global Market
    Table 84. Biosimilar Drug Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Biosimilar Drug Segment by Type
    Figure 2. Biosimilar Drug Segment by Application
    Figure 3. Global Biosimilar Drug Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Biosimilar Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Biosimilar Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. Biosimilar Drug Sales in Global Market: 2017-2028 (K Dose)
    Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Drug Revenue in 2021
    Figure 9. By Type - Global Biosimilar Drug Sales Market Share, 2017-2028
    Figure 10. By Type - Global Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Biosimilar Drug Price (USD/Dose), 2017-2028
    Figure 12. By Application - Global Biosimilar Drug Sales Market Share, 2017-2028
    Figure 13. By Application - Global Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Biosimilar Drug Price (USD/Dose), 2017-2028
    Figure 15. By Region - Global Biosimilar Drug Sales Market Share, 2017-2028
    Figure 16. By Region - Global Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Biosimilar Drug Sales Market Share, 2017-2028
    Figure 19. US Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Biosimilar Drug Sales Market Share, 2017-2028
    Figure 24. Germany Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. France Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Biosimilar Drug Sales Market Share, 2017-2028
    Figure 33. China Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. India Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Biosimilar Drug Sales Market Share, 2017-2028
    Figure 40. Brazil Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Biosimilar Drug Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Biosimilar Drug Sales Market Share, 2017-2028
    Figure 44. Turkey Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Biosimilar Drug Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Biosimilar Drug Production Capacity (K Dose), 2017-2028
    Figure 49. The Percentage of Production Biosimilar Drug by Region, 2020 VS 2027
    Figure 50. Biosimilar Drug Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Biosimilar Drug Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Drug Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Drug Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports